Infant formula recall raises safety concerns
A can of ByHeart powdered infant formula was spotted on a grocery store shelf weeks after a recall was issued due to contamination linked to infant botulism, prompting a swift backlash from food safety advocates and legal experts, reports BritPanorama.
The infant formula, which was recalled on November 11, 2025, has been associated with 51 cases of infant botulism across 19 states, as confirmed by the US Food and Drug Administration (FDA). Public health investigations indicated an unusually high number of cases in infants consuming the formula. Testing by health officials confirmed the presence of botulinum bacteria in several opened and unopened cans of the product.
Food safety attorney Bill Marler, representing families affected by the contamination, expressed his disbelief at seeing the formula on store shelves post-recall. Marler noted that he had filed complaints against retailers for failing to act swiftly enough to remove the product from their shelves. His sentiments echo a frustration among consumers and health experts regarding the efficacy of recall protocols.
In a statement, Kroger, the supermarket chain where the formula was found, insisted that they had adhered to their internal recall processes to prevent the sale of the contaminated product. However, it remains unclear how the can ended up on the shelf despite the recall measures. This incident has compounded ongoing scrutiny regarding the supermarket’s procedures in light of regulatory expectations.
The FDA has intensified its oversight of recalls in the wake of this incident, having issued warning letters to Kroger and other retailers, such as Target and Walmart, for selling the recalled formula. In December alone, inspections revealed that these retailers had cans and packages of ByHeart available for sale in 36 states.
“This situation is not unfamiliar to regulatory bodies,” stated Frank Yiannis, former FDA deputy commissioner for food policy. Yiannis underlined that compliance with product recalls is crucial for public safety, yet acknowledged that the speed and effectiveness of recalls can vary significantly among retailers. Regulatory bodies like the Consumer Product Safety Commission (CPSC) conduct periodic checks, but broader concerns remain that not all recalled products are swiftly removed from sale.
Indeed, recalls are a persistent challenge for retailers, often complicated by internal processes, employee awareness, and logistical execution. Historical cases have shown that lapses in compliance can lead to severe consequences, such as the civil penalty against TJX for failing to remove dangerous recalled products from their sales floors.
Child safety experts urge vigilance following this incident, particularly regarding baby products, which are often kept for extended periods and can be resold. “Parents should verify any secondhand products against the CPSC database to ensure they have not been recalled,” advised Yiannis.
The continuous rise in recalls, with the CPSC observing a significant increase to 357 in fiscal year 2025 from 238 in 2020, signifies an urgent need for improved compliance and tracking methods. Experts suggest that technology, such as RFID tagging, could facilitate better inventory management and expedite identification and removal of dangerous products.
In light of these developments, ByHeart halted production to audit its supply chain and expressed its regret over the incident, emphasizing the priority of consumer safety. The company acknowledged the gravity of the situation, stating, “We are deeply sorry for the distress and challenges this event has caused.” Yet, as the recall’s implications unfold, it raises pressing questions regarding oversight and accountability in infant formula safety amidst growing health concerns.
The case underscores the complexities of ensuring that recalled products are effectively tracked and removed from retail environments, a challenge regulators continue to grapple with as they seek to protect public health.
